A biomarker test identified tau pathology in Alzheimer's disease before fibrillary tangles developed. Neurofibrillary tangle formation can be prevented by targeting intermediate soluble tau assemblies ...

With two new treatments for Alzheimer’s disease approved in recent years, there’s growing hope for people at risk of the memory-robbing condition. But tests to detect the condition still lag behind.

"It is still possible to detect AD pathology, but not as precisely as one would like or in the way that is often suggested. A positive p-tau test could, for example, prompt physicians to perform other ...

Testing a person's blood for a type of protein called phosphorylated tau, or p-tau, could be used to screen for Alzheimer's disease with "high accuracy," even before symptoms begin to show, a new ...

Please provide your email address to receive an email when new articles are posted on . A clinical diagnostics company and biotech firm have announced a partnership to develop a blood-based tau ...

Quanterix expands access to p-Tau 217 blood test kit using antibody technology licensed from Lilly BILLERICA, Mass.--(BUSINESS WIRE)-- Quanterix Corporation (NASDAQ: QTRX), a company fueling ...

New test elevates the performance standard for blood biomarker tests intended for detecting amyloid pathology in individuals with cognitive impairment BILLERICA, Mass.--(BUSINESS WIRE)--Lucent ...

Laura holds a Master's in Experimental Neuroscience and a Bachelor's in Biology from Imperial College London. Her areas of expertise include health, medicine, psychology, and neuroscience. Laura holds ...

Plasma eMTBR-tau243 shows a strong correlation with tau pathology and cognitive decline, offering a less invasive alternative to tau-PET imaging. Study: Plasma MTBR-tau243 biomarker identifies tau ...

Elevated levels of p-tau 181 and 217 in cerebrospinal fluid are considered to reflect early Alzheimer's disease pathology. However, biomarker detection, which is now part of the diagnostic criteria, ...